
Embla Medical hf
CSE:EMBLA

Intrinsic Value
The intrinsic value of one
EMBLA
stock under the Base Case scenario is
38.1
DKK.
Compared to the current market price of 28.1 DKK,
Embla Medical hf
is
Undervalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Embla Medical hf
Fundamental Analysis


Revenue & Expenses Breakdown
Embla Medical hf
Balance Sheet Decomposition
Embla Medical hf
Current Assets | 397m |
Cash & Short-Term Investments | 87.6m |
Receivables | 121.9m |
Other Current Assets | 187.4m |
Non-Current Assets | 1.1B |
Long-Term Investments | 23.1m |
PP&E | 199.6m |
Intangibles | 873m |
Other Non-Current Assets | 46.4m |
Free Cash Flow Analysis
Embla Medical hf
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Embla Medical hf
Revenue
|
854.9m
USD
|
Cost of Revenue
|
-320.2m
USD
|
Gross Profit
|
534.7m
USD
|
Operating Expenses
|
-421.5m
USD
|
Operating Income
|
113.2m
USD
|
Other Expenses
|
-44.9m
USD
|
Net Income
|
68.3m
USD
|
EMBLA Profitability Score
Profitability Due Diligence
Embla Medical hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Score
Embla Medical hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
EMBLA Solvency Score
Solvency Due Diligence
Embla Medical hf's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Score
Embla Medical hf's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EMBLA Price Targets Summary
Embla Medical hf
According to Wall Street analysts, the average 1-year price target for
EMBLA
is 40.24 DKK
with a low forecast of 36.36 DKK and a high forecast of 44.94 DKK.
Dividends
Current shareholder yield for EMBLA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
EMBLA
stock under the Base Case scenario is
38.1
DKK.
Compared to the current market price of 28.1 DKK,
Embla Medical hf
is
Undervalued by 26%.